These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

12357 related articles for article (PubMed ID: 12575847)

  • 1. Bcl-2-related proteins, alpha-smooth muscle actin and amyloid deposits in aggressive and non-aggressive basal cell carcinomas.
    Bozdogan O; Erkek E; Atasoy P; Koçak M; Birol A; Caydere M
    Acta Derm Venereol; 2002; 82(6):423-7. PubMed ID: 12575847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stromal expression of actin is a marker of aggressiveness in basal cell carcinoma.
    Adegboyega PA; Rodriguez S; McLarty J
    Hum Pathol; 2010 Aug; 41(8):1128-37. PubMed ID: 20381122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal cell carcinoma with tumor epithelial and stromal giant cells: a variant of pleomorphic basal cell carcinoma.
    Meehan SA; Egbert BM; Rouse RV
    Am J Dermatopathol; 1999 Oct; 21(5):473-8. PubMed ID: 10535579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the bcl-2 homologue bax in normal human skin, psoriasis vulgaris and non-melanoma skin cancers.
    Tomková H; Fujimoto W; Arata J
    Eur J Dermatol; 1998 Jun; 8(4):256-60. PubMed ID: 9649682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. bcl-2 protein expression in aggressive and non-aggressive basal cell carcinomas.
    Ramdial PK; Madaree A; Reddy R; Chetty R
    J Cutan Pathol; 2000 Jul; 27(6):283-91. PubMed ID: 10885404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactivity for alpha-smooth muscle actin characterizes a potentially aggressive subgroup of little basal cell carcinomas.
    Pilloni L; Bianco P; Manieli C; Senes G; Coni P; Atzori L; Aste N; Faa G
    Eur J Histochem; 2009; 53(2):e14. PubMed ID: 19683985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression and localization of bcl-2 protein in normal skin and in non-melanoma skin cancers.
    Rodriguez-Villanueva J; Colome MI; Brisbay S; McDonnell TJ
    Pathol Res Pract; 1995 Jun; 191(5):391-8. PubMed ID: 7479356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the apoptosis-suppressing protein Bcl-2 in non-melanoma skin cancer.
    Verhaegh ME; Sanders CJ; Arends JW; Neumann HA
    Br J Dermatol; 1995 May; 132(5):740-4. PubMed ID: 7772478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of bcl-2 family member proteins in nonmelanoma skin cancer.
    Delehedde M; Cho SH; Sarkiss M; Brisbay S; Davies M; El-Naggar AK; McDonnell TJ
    Cancer; 1999 Apr; 85(7):1514-22. PubMed ID: 10193941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid in basal cell carcinoma and seborrheic keratosis.
    Olsen KE; Westermark P
    Acta Derm Venereol; 1994 Jul; 74(4):273-5. PubMed ID: 7976084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study of primary and recurrent basal cell and metatypical carcinomas of the skin.
    Kazantseva IA; Khlebnikova AN; Babaev VR
    Am J Dermatopathol; 1996 Feb; 18(1):35-42. PubMed ID: 8721589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunohistochemical study of basal cell carcinoma and trichoepithelioma.
    Poniecka AW; Alexis JB
    Am J Dermatopathol; 1999 Aug; 21(4):332-6. PubMed ID: 10446773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The altered expression of alpha-smooth muscle actin in basal cell epithelioma and its surrounding stroma: with special reference to proliferating cell nuclear antigen expression and adenoid differentiation.
    Tsukamoto H; Hayashibe K; Mishima Y; Ichihashi M
    Br J Dermatol; 1994 Feb; 130(2):189-94. PubMed ID: 7907224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A correlation of alpha-smooth muscle actin and invasion in micronodular basal cell carcinoma.
    Christian MM; Moy RL; Wagner RF; Yen-Moore A
    Dermatol Surg; 2001 May; 27(5):441-5. PubMed ID: 11359490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal α-Smooth Muscle Actin Positivity Is Associated With High-Risk Basal Cell Carcinomas.
    Krum Dos Santos AC; Lima D; Marchiori Bakos R; da Silva Cartell A; Rangel Bonamigo R
    Am J Dermatopathol; 2021 Dec; 43(12):e137-e140. PubMed ID: 34231496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic basal cell carcinoma exhibits reduced actin expression.
    Uzquiano MC; Prieto VG; Nash JW; Ivan DS; Gong Y; Lazar AJ; Diwan AH
    Mod Pathol; 2008 May; 21(5):540-3. PubMed ID: 18223552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. bcl-2 expression reliably distinguishes trichoepitheliomas from basal cell carcinomas.
    Smoller BR; Van de Rijn M; Lebrun D; Warnke RA
    Br J Dermatol; 1994 Jul; 131(1):28-31. PubMed ID: 8043419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunomorphological features of cutaneous basal-cell carcinoma].
    Chuprov IN
    Vopr Onkol; 2008; 54(6):715-9. PubMed ID: 19241845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of immunostaining for bcl-2 and CD34 and the lectin peanut agglutinin in differentiating between basal cell carcinomas and trichoepitheliomas.
    Basarab T; Orchard G; Russell-Jones R
    Am J Dermatopathol; 1998 Oct; 20(5):448-52. PubMed ID: 9790103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bax/bcl-2: cellular modulator of apoptosis in feline skin and basal cell tumours.
    Madewell BR; Gandour-Edwards R; Edwards BF; Matthews KR; Griffey SM
    J Comp Pathol; 2001; 124(2-3):115-21. PubMed ID: 11222007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 618.